Daniel Bednarik is a biopharmaceutical research expert who is the Vice President of the operations of the Molecular Engineering Unit at Intrexon. This presentation discusses some of the lesser-known aspects of translational medicine and how it has, and can continue to, positively influence our understanding of medicine as well as our capabilities to treat people.